A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
11/2001
11/22/2001	WO2000055633A9 Methods of screening for colorectal cancer modulators
11/22/2001	US20010044937 Transgenic intracytoplasmic sperm injection, retroviral gene transfer, intracytoplasmic nuclear injection, and pronuclear injection; useful as models for human disease/diagnosis, assessing safety and efficiency of drug and gene therapy
11/22/2001	US20010044420 Treatment of mammalian cancer
11/22/2001	US20010044417 Compound containing a labile disulfide bond
11/22/2001	US20010044413 First nucleic acid molecule encoding cell growth stimulating agent, second nucleic acid encoding a bioactive agent, and a biocompatible substance capable of cellular infiltration; for systemic delivery of a bioactive agent
11/22/2001	US20010044412 Gene transfer by forming a complex of an amphiphile binding agent such as a cyclodextrin, an amphiphile, and a polynucleotide, delivering complex to cell and expressing polynucleotide; gene therapy
11/22/2001	US20010044149 Transfer of heterologous gene sequences into cells using equine infectious anemia virus-derived vectors for gene delivery
11/22/2001	US20010043922 Recombinants of the multiply deficient adenoviral vectors; a therapeutic method and their use particularly relating to gene therapy and vaccination
11/22/2001	US20010043921 A retroviral vector of a heterologous nucleic acid sequence as well as at least one sequence allowing site-specific integration of the sequence into a non-coding region of a genome; gene therapy of genetic defects; viricides
11/22/2001	US20010043920 Delivering a dosage of a growth factor-encoding transgene composition to preselected delivery sites in the brain where the encoded growth factor is expressed and stimulates axonal growth; mimimally invasive; Alzheimer's, Parkinson diseases
11/22/2001	US20010042932 Process for preparing microparticles through phase inversion phenomena
11/22/2001	DE10009119A1 Vertebraten Globin Vertebrate globin
11/22/2001	CA2409414A1 Ssa-56kda polypeptide and its fragments and polynucleotides encoding said polypeptides and therapeutic uses
11/22/2001	CA2409154A1 Compositions, kits, and methods for identification and modulation of t helper-1 and t helper-2 cells and diseases associated therewith
11/22/2001	CA2409068A1 Novel dual oxidases as mitogenic and endocrine regulators
11/22/2001	CA2408885A1 Vectors for dna delivery
11/22/2001	CA2408830A1 Treatment of human papillomavirus (hpv)-infected cells
11/22/2001	CA2408827A1 Novel human lipocalin homologs and polynucleotides encoding the same
11/22/2001	CA2408729A1 Delivery systems for treatment of vascular disease
11/22/2001	CA2408719A1 Antiproliferative drug and delivery device
11/22/2001	CA2408608A1 Antiinflammatory drug and delivery device
11/22/2001	CA2408530A1 Novel deoxynucleoside kinase enzyme variants
11/22/2001	CA2408433A1 Synthetic gagpol genes and their uses
11/22/2001	CA2408374A1 Mutation in the .beta.2 nicotinic acetylcholine receptor subunit associated with nocturnal frontal lobe epilepsy
11/22/2001	CA2408373A1 Therapeutic approaches to diseases by suppression of the nurr subfamily of nuclear transcription factors
11/21/2001	EP1156123A1 Method for detecting a variation of GH1 as indicator of growth hormone dysfunction
11/21/2001	EP1156119A2 Anti-cancer gene therapy by modulation of immune or inflammatory response
11/21/2001	EP1156118A1 Virus vector
11/21/2001	EP1156112A1 Synthetic gagpol genes and their uses
11/21/2001	EP1156110A2 G-protein coupled receptor (HFGAN72Y)
11/21/2001	EP1155136A2 Helper adenovirus / helper-dependent adenovirus vector system based on site-specific recombinase activity
11/21/2001	EP1155131A2 Compositions and methods for non-targeted activation of endogenous genes
11/21/2001	EP1155126A2 Genes associated with diseases of the colon
11/21/2001	EP1155035A2 Synthetic peptide of regulatory virus protein r (vpr) of human immunodeficiency virus type 1 (hiv-1) and the utilization thereof
11/21/2001	EP1154786A2 Methods and compositions for altering mucus secretion
11/21/2001	EP1154756A2 Antibody fragment-targeted immunoliposomes for systemic gene delivery
11/21/2001	EP1154692A1 A method of controlling fungal pathogens, and agents useful for same
11/21/2001	EP0836645A4 Dry powder formulations of polynucleotide complexes
11/21/2001	EP0833667A4 Stabilization of polynucleotide complexes
11/21/2001	EP0644944B1 Adeno-associated virus with inverted terminal repeat sequences as promoter for the in vivo transfer of a functional cftr gene
11/21/2001	CN1323350A Adenovirus vectors containing cell status-specific response elements and methods of use thereof
11/21/2001	CN1323348A Delivery system for porcine somatotropin
11/21/2001	CN1322574A Insulin B chain gene vaccine prepn
11/21/2001	CN1322572A Transforming growth factor-beta gene vaccine as diabetes and nephropathy preventing preparation
11/21/2001	CN1075078C Producing process of stem cell factor
11/20/2001	US6320038 Promoter for neuropeptide FF and use thereof for therapy and diagnostics
11/20/2001	US6320036 GbpA
11/20/2001	US6319907 Administering latency associated peptide, or a peptide analogue that is capable of maintaining transforming growth factor .beta. in latent state
11/20/2001	US6319906 Oligonucleotide compositions and methods for the modulation of the expression of B7 protein
11/20/2001	US6319905 Method of controlling L-Dopa production and of treating dopamine deficiency
11/20/2001	US6319716 Generating expression vectors; link heterologous sequences, insert into cells, allow homologous recombination, recover expression vectors
11/20/2001	US6319713 Methods and compositions for polypeptide engineering
11/20/2001	US6319710 Isolated nucleic acid molecule operatively linked to a regulatory sequence
11/20/2001	US6319709 Tumor cells with increased immunogenicity and uses therefor
11/20/2001	US6319708 Method for increasing life-span
11/20/2001	US6319703 Recombinant virus vectors
11/20/2001	US6319693 Cloning of chicken anemia virus DNA
11/20/2001	US6319689 Nucleotide sequence which code aspartic protease; for treatment of alzheimer's disease, cancer; for hormone processing
11/20/2001	US6319688 Polynucleotide encoding human sodium dependent phosphate transporter (IPT-1)
11/20/2001	US6319666 Treating humans for viral infections; incubate human with antigen, monitor immunological response, screen for presence of viral proteins
11/20/2001	US6319496 Generation of human cytotoxic T-cells specific for carcinoma self-associated antigens and uses thereof
11/20/2001	US6319495 Method for restoring glucose responsiveness to insulin secretion
11/20/2001	US6319493 Treatment of neoplastic disease with interleukin-10
11/15/2001	WO2001086002A2 Compositions, kits, and methods for identification, assessment, prevention, and therapy of psoriasis
11/15/2001	WO2001085993A2 Method for detecting growth hormone variations in humans, the variations and their uses
11/15/2001	WO2001085981A2 Methods for stimulating nervous system regeneration and repair by regulating arginase i and polyamine synthesis
11/15/2001	WO2001085980A2 Enzymatic assays for screening anti-cancer agents
11/15/2001	WO2001085974A2 Retroviral vectors comprising an enhanced 3' transcription termination structure
11/15/2001	WO2001085973A1 Antisense type gene trap vector
11/15/2001	WO2001085961A2 Human caspase-12
11/15/2001	WO2001085960A1 Bacterial carboxypeptidase cpg2 variants and their use in gene directed enzyme prodrug therapy
11/15/2001	WO2001085959A2 Regulation of human lysostaphin-like protease
11/15/2001	WO2001085955A1 Rh116 polypeptides and its fragments and polynucleotides encoding said polypeptides and therapeutic uses
11/15/2001	WO2001085940A2 USE OF hTAFII80 AND ISOFORMS THEREOF FOR INDUCING APOPTOSIS
11/15/2001	WO2001085938A1 Modified es cells and es cell-specific gene
11/15/2001	WO2001085935A2 Endothelial differentiation gene 6-like g protein coupled receptor
11/15/2001	WO2001085932A2 Immunogenic polypeptides encoded by mage minigenes and uses thereof
11/15/2001	WO2001085926A2 Nucleotide sequences involved in increasing or decreasing mammalian ovulation rate
11/15/2001	WO2001085917A2 A device
11/15/2001	WO2001085790A2 Mammalian cytokine receptor subunit proteins, related reagents and methods
11/15/2001	WO2001085789A2 Extracellular domain of ryk protein for regulating angiogenesis
11/15/2001	WO2001085785A2 Ph domain-interacting protein
11/15/2001	WO2001085784A2 POLYNUCLEOTIDES ENCODING FOR POLYMORPHIC ISOFORMS OF THE PTHrP PROTEIN, THE ENCODED PROTEINS AND THEIR THERAPEUTIC APPLICATIONS THEREOF
11/15/2001	WO2001085781A2 Repair of nerve damage
11/15/2001	WO2001085779A2 Protein complexes and assays for screening anti-cancer agents
11/15/2001	WO2001085762A2 Cancer diagnosis and assays for screening anti-cancer agents
11/15/2001	WO2001085207A2 Modulation of antigen processing using phagocytic cells
11/15/2001	WO2001085196A2 Cxcr4 antagonist treatment of hematopoietic cells
11/15/2001	WO2001084933A1 A homeodomain protein code specifying progenitor cell identity and neuronal fate in the ventral neural tube
11/15/2001	WO2001042487A3 Device for extraction of nucleic acids
11/15/2001	WO2001038350A3 85kDa NEISSERIAL ANTIGEN
11/15/2001	WO2001036656A3 A complex between hyaluronic acid and a biomolecule and its use
11/15/2001	WO2001032878A3 A novel polypeptide hormone phosphatonin
11/15/2001	WO2001019974A3 Recombinant microorganisms
11/15/2001	WO2001019853A3 Cell transfection
11/15/2001	WO2001015737A3 Method for coupling molecules
11/15/2001	WO2001010899A3 Treatment of liver disease and injury with cxc chemokines
11/15/2001	WO2001003717A3 Methods of inducing cell death
11/15/2001	WO2001002594A3 DNA CONSTRUCTS BASED ON THE eIF4A GENE PROMOTER
11/15/2001	WO2001002550A3 Cell death related drug targets in yeast and fungi

1 ... 631 632 633 634 635 636 637 638 639 640 641 642 643 644 645 646 647 648 649 650 651 ... 870